27
19M
21
2.08
1
0.22
4
- Stages of investment
- Areas of investment
Summary
The company was established in Asia in Singapore. The main office of represented VC is situated in the Singapore.
Among the most popular portfolio startups of the fund, we may highlight Tessa Therapeutics, ONE Championship. We can highlight the next thriving fund investment areas, such as Media and Entertainment, Biotechnology. Besides, a startup needs to be aged 16-20 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Singapore.
The overall number of key employees were 5.
The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Heliconia Capital Management works on 4 percentage points less the average amount of lead investments. The typical startup value when the investment from Heliconia Capital Management is 100-500 millions dollars. The important activity for fund was in 2017. The fund is generally included in 2-6 deals every year.
The typical case for the fund is to invest in rounds with 2-3 participants. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Singtel Innov8, Sequoia Capital India. In the next rounds fund is usually obtained by Temasek Holdings, Sequoia Capital, Greenoaks Capital.
Investments analytics
Analytics
- Total investments
- 27
- Lead investments
- 1
- Exits
- 4
- Rounds per year
- 2.08
- Follow on index
- 0.22
- Investments by industry
- Health Care (6)
- Consumer Goods (5)
- Biotechnology (4)
- E-Commerce (4)
- Retail (4) Show 40 more
- Investments by region
-
- Singapore (26)
- United States (1)
- Peak activity year
- 2021
- Number of Unicorns
- 2
- Number of Decacorns
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 134M
- Group Appearance index
- 0.59
- Avg. company exit year
- 18
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Lucence Health | 20 Nov 2019 | Biotechnology, Health Care, Health Diagnostics, Genetics, Medical | Early Stage Venture | 20M | United States, California, Palo Alto |
| Tessa Therapeutics | 09 Jun 2022 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 126M | Central, Singapore, Singapore |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.